BioMarin Pharmaceutical
BMRN
#1907
Rank
โ‚ฌ8.81 B
Marketcap
45,87ย โ‚ฌ
Share price
-0.78%
Change (1 day)
-27.39%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ1.33 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are โ‚ฌ1.33 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ1.27 B-25.19%
2023-12-31โ‚ฌ1.70 B3.5%
2022-12-31โ‚ฌ1.65 B7.57%
2021-12-31โ‚ฌ1.53 B8.43%
2020-12-31โ‚ฌ1.41 B1.21%
2019-12-31โ‚ฌ1.39 B9.71%
2018-12-31โ‚ฌ1.27 B-16.12%
2017-12-31โ‚ฌ1.52 B27.2%
2016-12-31โ‚ฌ1.19 B-1.61%
2015-12-31โ‚ฌ1.21 B55.96%
2014-12-31โ‚ฌ0.77 B19.14%
2013-12-31โ‚ฌ0.65 B56.53%
2012-12-31โ‚ฌ0.41 B1.85%
2011-12-31โ‚ฌ0.41 B0.04%
2010-12-31โ‚ฌ0.41 B-1.27%
2009-12-31โ‚ฌ0.41 B-7.85%
2008-12-31โ‚ฌ0.45 B4.85%
2007-12-31โ‚ฌ0.42 B64.08%
2006-12-31โ‚ฌ0.26 B13.76%
2005-12-31โ‚ฌ0.23 B3.79%
2004-12-31โ‚ฌ0.22 B101.69%
2003-12-31โ‚ฌ0.10 B852.42%
2002-12-31โ‚ฌ11.54 M-16.83%
2001-12-31โ‚ฌ13.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.00 B-24.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ70.77 M-94.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.70 B-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ56.71 B 4,137.50%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
โ‚ฌ0.54 B-59.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.11 B-91.57%๐Ÿ‡บ๐Ÿ‡ธ USA